Revista Habanera de Ciencias Médicas, 2010 Se realizó un estudio descriptivo, retrospectivo, de las pacientes con diagnóstico de cáncer de mama metastásico atendidas en el INOR, de enero 2000 a diciembre 2003.
Haslen Hassiul Cáceres Lavernia +4 more
doaj
Overview of adjuvant treatment in early breast cancer [PDF]
El beneficio del tratamiento adyuvante del cáncer de mama ha sido bien establecido en las últimas décadas, logrando reducir el riesgo de recidiva sistémica. La finalidad de dicha terapia consiste en eliminar la enfermedad micrometastásica.
Martín, Miguel, Puente, Javier
core +1 more source
Relevancia y prevalencia de los parámetros histopatológicos y subtipos moleculares del cáncer de mama en mujeres del área costera de Ecuador atendidas en una institución de Salud Pública [PDF]
, 2023 Lourdes González-Longoria Boada +2 more
openalex +1 more source
The Vietnamese swine as a translational model of invasive ductal carcinoma of the breast
Animal Models and Experimental Medicine, EarlyView.The flow diagram outlines the chemical induction of breast tumors through a single intraperitoneal dose of MNU. Tumor development was assessed using ultrasound and clinical examination. After 14 weeks, mammary tissue was collected and histologically analyzed to evaluate structural similarities between sows and humans, the carcinogenic potential of MNU,
Claudia Elizabeth Vera‐Tizatl +6 more
wiley +1 more source
Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas
Annals of Neurology, EarlyView.Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek +7 more
wiley +1 more source
[Inconsistency in the effective implementation of care plans for breast cancer survivors]. [PDF]
Aten PrimariaLópez Cornudella L, Lozano A.
europepmc +1 more source
Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia [PDF]
Biomedica, 2023 Rodríguez M +4 more
europepmc +1 more source
Cuestionarios para medir la calidad de vida en cáncer de mama
, 2015 Lyda Fabiola Vallejo-Castillo +2 more
openalex +2 more sources
Metabolism‐Regulating Nanomedicines for Cancer Therapy
Advanced NanoBiomed Research, EarlyView.This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley +1 more source
Survival time analysis in women with breast cancer using distributional regression models. [PDF]
Cad Saude PublicaLima IDS +6 more
europepmc +1 more source